These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 22823169)

  • 21. Pharmacophore-based virtual screening: a review of recent applications.
    Kim KH; Kim ND; Seong BL
    Expert Opin Drug Discov; 2010 Mar; 5(3):205-22. PubMed ID: 22823018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Models and screening assays for drug discovery in osteoporosis.
    Rissanen JP; Halleen JM
    Expert Opin Drug Discov; 2010 Dec; 5(12):1163-74. PubMed ID: 22822719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exemplification of the challenges associated with utilising fluorescence intensity based assays in discovery.
    Gul S; Gribbon P
    Expert Opin Drug Discov; 2010 Jul; 5(7):681-90. PubMed ID: 22823207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacophore models for GABA(A) modulators: implications in CNS drug discovery.
    Ghoshal N; Vijayan RS
    Expert Opin Drug Discov; 2010 May; 5(5):441-60. PubMed ID: 22823129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human kinome drug discovery and the emerging importance of atypical allosteric inhibitors.
    Eglen RM; Reisine T
    Expert Opin Drug Discov; 2010 Mar; 5(3):277-90. PubMed ID: 22823023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design of chemical libraries for screening.
    Villar HO; Hansen MR
    Expert Opin Drug Discov; 2009 Dec; 4(12):1215-20. PubMed ID: 23480462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of estrogen receptor modulators: a review of virtual screening and SAR efforts.
    Xu X; Yang W; Li Y; Wang Y
    Expert Opin Drug Discov; 2010 Jan; 5(1):21-31. PubMed ID: 22823969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-mammalian animal models of Parkinson's disease for drug discovery.
    Lim KL
    Expert Opin Drug Discov; 2010 Feb; 5(2):165-76. PubMed ID: 22822916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Approaches to protozoan drug discovery: phenotypic screening.
    Sykes ML; Avery VM
    J Med Chem; 2013 Oct; 56(20):7727-40. PubMed ID: 23927763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The GRID/CPCA approach in drug discovery.
    Rocha JR; Freitas RF; Montanari CA
    Expert Opin Drug Discov; 2010 Apr; 5(4):333-46. PubMed ID: 22823086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. What does systems biology mean for biomarker discovery?
    Azuaje F
    Expert Opin Med Diagn; 2010 Jan; 4(1):1-10. PubMed ID: 23496106
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opportunities and limits of cell-based assay miniaturization in drug discovery.
    Carstens C; Elbracht R; Gärtner C; Becker H
    Expert Opin Drug Discov; 2010 Jul; 5(7):673-9. PubMed ID: 22823206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of phage display technology for the determination of the targets for small-molecule therapeutics.
    Takakusagi Y; Takakusagi K; Sugawara F; Sakaguchi K
    Expert Opin Drug Discov; 2010 Apr; 5(4):361-89. PubMed ID: 22823088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Micropatterned surfaces: techniques and applications in cell biology.
    Quist AP; Oscarsson S
    Expert Opin Drug Discov; 2010 Jun; 5(6):569-81. PubMed ID: 22823168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advances in targeted therapeutic agents.
    Nicolaides NC; Sass PM; Grasso L
    Expert Opin Drug Discov; 2010 Nov; 5(11):1123-40. PubMed ID: 22827748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent patents in the discovery of small molecule inhibitors of JAK3.
    Wilson LJ
    Expert Opin Ther Pat; 2010 May; 20(5):609-23. PubMed ID: 20402545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting kinases for the treatment of inflammatory diseases.
    Müller S; Knapp S
    Expert Opin Drug Discov; 2010 Sep; 5(9):867-81. PubMed ID: 22823261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biasing conformational ensembles towards bioactive-like conformers for ligand-based drug design.
    Musafia B; Senderowitz H
    Expert Opin Drug Discov; 2010 Oct; 5(10):943-59. PubMed ID: 22823989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patented PDE10A inhibitors: novel compounds since 2007.
    Kehler J; Kilburn JP
    Expert Opin Ther Pat; 2009 Dec; 19(12):1715-25. PubMed ID: 19939189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer Drug Development: New Targets for Cancer Treatment.
    Curt GA
    Oncologist; 1996; 1(3):II-III. PubMed ID: 10387987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.